Clinical Trials Directory

Trials / Completed

CompletedNCT03789357

Prevalence of Primary Aldosteronism in Patients With Stroke

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Changi General Hospital · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers

Summary

Strokes leads to significant morbidity and mortality, and hypertension is the most important risk factor for strokes. It is estimated that up to 10% of patients with hypertension have the underlying, treatable condition of primary aldosteronism. Hence, we hypothesize that the prevalence of primary aldosteronism is high in patients with strokes, a complication of long-standing hypertension. Patients admitted with an acute stroke to the Acute Stroke Unit, Changi General Hospital, will be screened for Primary Aldosteronism three months post-stroke, and confirmatory tests will be done with saline-infusion test.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAldosterone renin ratioAldosterone Renin Ratio to screen for Primary Aldosteronism

Timeline

Start date
2018-05-01
Primary completion
2021-07-31
Completion
2021-09-30
First posted
2018-12-28
Last updated
2022-05-20

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03789357. Inclusion in this directory is not an endorsement.

Prevalence of Primary Aldosteronism in Patients With Stroke (NCT03789357) · Clinical Trials Directory